Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients
Huimin Fan, Xinyang Sun, Wei Guo, et al.
Journal of Psychiatric Research (2014) Vol. 59, pp. 45-52
Closed Access | Times Cited: 123

Showing 26-50 of 123 citing articles:

The miRNome of Depression
Dariusz Żurawek, Gustavo Turecki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11312-11312
Open Access | Times Cited: 42
Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression
Yentl Y. van der Zee, Lars Eijssen, Philipp Mews, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4536-4549
Open Access | Times Cited: 37
A new perspective on depression and neuroinflammation: Non-coding RNA
Shanyao Zhou, Rui Chen, Yanling She, et al.
Journal of Psychiatric Research (2022) Vol. 148, pp. 293-306
Closed Access | Times Cited: 34
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 30
The role of microRNAs in depression
Ruidong Ding, Dingyuan Su, Qian Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior
Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4664-4664
Open Access | Times Cited: 18
Pathogenetic and therapeutic applications of microRNAs in major depressive disorder
Yogesh Dwivedi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 341-348
Open Access | Times Cited: 62
Identification of a MicroRNA Signature for the Diagnosis of Fibromyalgia
German Cerdá‐Olmedo, Armando V. Mena-Durán, V. Monsalve, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0121903-e0121903
Open Access | Times Cited: 56
MicroRNAs and psychiatric disorders: From aetiology to treatment
Alessia Luoni, Marco Andrea Riva
Pharmacology & Therapeutics (2016) Vol. 167, pp. 13-27
Closed Access | Times Cited: 56
Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder
Sheng-Yu Lee, Ru‐Band Lu, Liang‐Jen Wang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 49
MicroRNAs expressed in depression and their associated pathways: A systematic review and a bioinformatics analysis
Camila Perelló Ferrúa, Roberta Giorgi, Laísa Camerini da Rosa, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 100, pp. 101650-101650
Open Access | Times Cited: 45
Role of Monocyte-Derived MicroRNA106b∼25 in Resilience to Social Stress
Madeline L. Pfau, Caroline Ménard, Flurin Cathomas, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 6, pp. 474-482
Open Access | Times Cited: 43
Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response
Lisha Zhou, Yingying Zhu, Wangyang Chen, et al.
Journal of Affective Disorders (2021) Vol. 286, pp. 80-86
Closed Access | Times Cited: 40
MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
Robert Petty, Neil E. McCarthy, Rifca Le Dieu, et al.
PLoS ONE (2016) Vol. 11, Iss. 3, pp. e0150904-e0150904
Open Access | Times Cited: 45
Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder
Rosie M. Walker, Joanna Rybka, Susan M. Anderson, et al.
Journal of Psychiatric Research (2015) Vol. 62, pp. 48-55
Open Access | Times Cited: 41
Biological correlates of early life stressful events in major depressive disorder
Rosana Carvalho Silva, Elisabetta Maffioletti, Massimo Gennarelli, et al.
Psychoneuroendocrinology (2020) Vol. 125, pp. 105103-105103
Closed Access | Times Cited: 39
Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants
Raoul Belzeaux, Rixing Lin, Gustavo Turecki
CNS Drugs (2017) Vol. 31, Iss. 4, pp. 253-262
Closed Access | Times Cited: 39
Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review
Saurabh Srivastav, Susanne Walitza, Edna Grünblatt
ADHD Attention Deficit and Hyperactivity Disorders (2017) Vol. 10, Iss. 1, pp. 49-63
Closed Access | Times Cited: 39
Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
Dahua Fan, Mei-qun Cao, Qiong Liu, et al.
Neural Regeneration Research (2018) Vol. 13, Iss. 5, pp. 837-837
Open Access | Times Cited: 37
Integrative Analysis of Sex-Specific microRNA Networks Following Stress in Mouse Nucleus Accumbens
Madeline L. Pfau, Immanuel Purushothaman, Jian Feng, et al.
Frontiers in Molecular Neuroscience (2016) Vol. 9
Open Access | Times Cited: 36
miRNAs in depression vulnerability and resilience: novel targets for preventive strategies
Nicola Lopizzo, Valentina Zonca, Nadia Cattane, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 9, pp. 1241-1258
Open Access | Times Cited: 34
The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice
Zhenghua Hou, Wenhao Jiang, Yingying Yin, et al.
Neuroscience Bulletin (2016) Vol. 32, Iss. 4, pp. 389-397
Open Access | Times Cited: 32
The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder
Piotr Czarny, Katarzyna Białek, Sylwia Ziółkowska, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 167-167
Open Access | Times Cited: 27
Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways
Masaki Kato, Haruhiko Ogata, Hidetoshi Tahara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3873-3873
Open Access | Times Cited: 17
The Clinical Utility of Biomarkers in Diagnosing Major Depressive Disorder in Adults: A Systematic Review of Literature From 2013 to 2023
Shin‐Yii Ang, Roger Ho, Roger S. McIntyre, et al.
Psychiatry Investigation (2025) Vol. 22, Iss. 4, pp. 341-356
Closed Access

Scroll to top